Southern First Bancshares (NASDAQ:SFST) Upgraded to Buy at Wall Street Zen
Wall Street Zen upgraded shares of Southern First Bancshares (NASDAQ:SFST – Free Report) from a hold rating to a buy rating in a report issued on Sunday. Other research analysts have also recently issued research reports about the stock. Piper Sandler lifted their price objective on shares of Southern First Bancshares from $54.00 to $64.00 […]
Leonardo DRS (NASDAQ:DRS) Upgraded to “Buy” at Wall Street Zen
Wall Street Zen upgraded shares of Leonardo DRS (NASDAQ:DRS – Free Report) from a hold rating to a buy rating in a report released on Saturday morning. Several other research analysts have also commented on the stock. Truist Financial set a $59.00 price objective on shares of Leonardo DRS in a research note on Wednesday, […]
TuHURA Biosciences (NASDAQ:HURA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of TuHURA Biosciences (NASDAQ:HURA – Free Report) from a sell rating to a hold rating in a research note issued to investors on Monday morning. A number of other research analysts have also recently issued reports on HURA. HC Wainwright reaffirmed a “buy” rating and issued a $10.00 target price […]
Safe and Green Development (NASDAQ:RENX) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Safe and Green Development (NASDAQ:RENX – Free Report) to a sell rating in a research report released on Monday. Safe and Green Development Trading Up 46.6% NASDAQ:RENX opened at $2.61 on Monday. The company has a market cap of $6.06 million, a PE ratio of -0.58 and a beta […]
First Northwest Bancorp (NASDAQ:FNWB) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of First Northwest Bancorp (NASDAQ:FNWB – Free Report) from a sell rating to a hold rating in a research report released on Sunday. Several other research analysts have also commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of First Northwest Bancorp in a research note […]
Spero Therapeutics (NASDAQ:SPRO) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Spero Therapeutics (NASDAQ:SPRO – Free Report) from a hold rating to a strong-buy rating in a research note released on Sunday morning. Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Spero Therapeutics in a research report on Thursday, January 22nd. One analyst has rated the stock […]
Healthcare Services Group (NASDAQ:HCSG) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Healthcare Services Group (NASDAQ:HCSG – Free Report) from a hold rating to a buy rating in a report issued on Sunday morning. A number of other research analysts have also commented on HCSG. Royal Bank Of Canada began coverage on shares of Healthcare Services Group in a research report […]
Uranium Royalty (NASDAQ:UROY) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Uranium Royalty (NASDAQ:UROY – Free Report) from a hold rating to a buy rating in a report issued on Saturday morning. Several other brokerages also recently issued reports on UROY. Raymond James Financial reaffirmed a “market perform” rating on shares of Uranium Royalty in a research report on Wednesday, […]
Maze Therapeutics (NASDAQ:MAZE) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Maze Therapeutics (NASDAQ:MAZE – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning. A number of other equities analysts have also recently commented on MAZE. Wedbush lifted their price objective on shares of Maze Therapeutics from $43.00 to $58.00 and […]
Cognyte Software (NASDAQ:CGNT) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Cognyte Software (NASDAQ:CGNT – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday morning. CGNT has been the topic of several other research reports. Lake Street Capital initiated coverage on shares of Cognyte Software in a research report on […]
EHang (NASDAQ:EH) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of EHang (NASDAQ:EH – Free Report) from a sell rating to a hold rating in a research note published on Saturday. A number of other brokerages have also recently weighed in on EH. Bank of America reissued a “buy” rating on shares of EHang in a research note on Thursday, […]
Niagen Bioscience (NASDAQ:NAGE) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) from a hold rating to a buy rating in a report issued on Saturday. A number of other brokerages have also recently weighed in on NAGE. Weiss Ratings restated a “hold (c)” rating on shares of Niagen Bioscience in a report on Thursday, […]
Noodles & Company (NASDAQ:NDLS) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Noodles & Company (NASDAQ:NDLS – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Noodles & Company in a report on Thursday, January 22nd. One analyst has rated the […]
Onespan (NASDAQ:OSPN) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Onespan (NASDAQ:OSPN – Free Report) from a hold rating to a buy rating in a research note released on Saturday morning. Several other research firms have also commented on OSPN. DA Davidson reduced their price objective on Onespan from $13.00 to $12.00 and set a “neutral” rating for the […]
Vericel (NASDAQ:VCEL) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Vericel (NASDAQ:VCEL – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday morning. VCEL has been the topic of a number of other reports. Truist Financial cut their price target on shares of Vericel from $50.00 to $45.00 and […]
NPT (NASDAQ:NPT) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of NPT (NASDAQ:NPT – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday. Separately, Weiss Ratings assumed coverage on NPT in a report on Friday, January 16th. They set a “sell (e-)” rating for the company. One equities research analyst […]
Biomea Fusion (NASDAQ:BMEA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Biomea Fusion (NASDAQ:BMEA – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. BMEA has been the topic of several other research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Biomea Fusion in a research note […]
Airgain (NASDAQ:AIRG) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Airgain (NASDAQ:AIRG – Free Report) to a hold rating in a research note published on Saturday. Several other analysts have also issued reports on the stock. Lake Street Capital initiated coverage on shares of Airgain in a research report on Wednesday, January 21st. They issued a “buy” rating and […]
Dave & Buster’s Entertainment (NASDAQ:PLAY) Upgraded to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Dave & Buster’s Entertainment (NASDAQ:PLAY – Free Report) from a sell rating to a hold rating in a research report report published on Sunday. A number of other equities analysts also recently weighed in on the company. Weiss Ratings reissued a “sell (d)” rating on shares of Dave & […]
Victory Capital (NASDAQ:VCTR) Upgraded to “Buy” at Wall Street Zen
Wall Street Zen upgraded shares of Victory Capital (NASDAQ:VCTR – Free Report) from a hold rating to a buy rating in a report published on Sunday. Other equities research analysts also recently issued reports about the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of Victory Capital in a research note on Wednesday, […]
Pyxis Oncology (NASDAQ:PYXS) Upgraded to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday. Several other research analysts also recently commented on PYXS. HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Pyxis Oncology […]
Quantum Biopharma (NASDAQ:QNTM) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Quantum Biopharma (NASDAQ:QNTM – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Quantum Biopharma in a research report on Monday, December 29th. One analyst has rated the stock with […]
Sutro Biopharma (NASDAQ:STRO) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Sutro Biopharma (NASDAQ:STRO – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. A number of other analysts have also weighed in on the stock. Wells Fargo & Company upgraded shares of Sutro Biopharma from an “equal weight” rating […]
Asure Software (NASDAQ:ASUR) Upgraded to Buy at Wall Street Zen
Wall Street Zen upgraded shares of Asure Software (NASDAQ:ASUR – Free Report) from a hold rating to a buy rating in a research note released on Saturday. Other analysts also recently issued research reports about the stock. Barrington Research reaffirmed an “outperform” rating and set a $15.00 target price on shares of Asure Software in […]
S&T Bancorp (NASDAQ:STBA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of S&T Bancorp (NASDAQ:STBA – Free Report) from a sell rating to a hold rating in a research note released on Sunday morning. Several other research analysts have also commented on the stock. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of S&T Bancorp in a report on Monday, […]
last updated on 6 Apr 15:02